Friday, May 1, 2009

Iezzoni leads Institute for Health Policy

Lisa I. Iezzoni

Lisa I. Iezzoni, MD, MSc, has been named director of the MGH/Partners Institute for Health Policy (IHP). She succeeds David Blumenthal, MD, MPP, who recently resigned from his roles at MGH to serve as national coordinator for Healthcare Information Technology in the U.S. Department of Health and Human Services.

Iezzoni has been associate director of the IHP since 2006 and is a leading authority on risk adjustment for cost and quality measurement as well as health policy and access issues. She has made many contributions to academia, research, and health policy and delivery, including authoring three books and dozens of articles on topics related to assessing severity of illness, measuring complications of inpatient care, and health care disparities affecting persons with disabilities. She has led health policy-related studies for the Agency for Healthcare Research and Quality, the Health Care Financing Administration, and private foundations. She also has served on the editorial boards of 11 medical and health services research journals. Before joining MGH, she spent 16 years as co-director of research in the general medicine division of Beth Israel Deaconess Medical Center (BIDMC), where she had the distinction of being the first woman at BIDMC to be appointed a Harvard Medical School (HMS) professor of Medicine.

Iezzoni’s contributions to national health policy were recognized by the Institute of Medicine of the National Academy of Sciences in 2000, when she was named a member. Since 2008, she has served on the U.S. Secretary’s Advisory Committee on Health Promotion and Disease Prevention Objectives for 2020.

A summa cum laude graduate of Duke University, Iezzoni completed a master’s program from Harvard School of Public Health’s Health Policy and Management program and received her medical degree from HMS.

Browse the Entire Newsroom Archive

Back to Top